SCHEMBL27700477

SCHEMBL27700477

Cc1cc2c(Cl)c(C(=O)N3CCC(Cc4ccccc4)CC3)ccc2[nH]1

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
CYP2C9 P11712 4/20 0.57
CYP2C19 P33261 4/20 0.57
MAPK14 Q16539 4/20 0.57
HTR2B P41595 2/20 0.57
MAPT P10636 1/20 0.55
GRIN2D O15399 3/20 0.54
GRIN3B O60391 3/20 0.54
GRIN1 Q05586 3/20 0.54
GRIN2A Q12879 3/20 0.54
GRIN2B Q13224 3/20 0.54
GRIN2C Q14957 3/20 0.54
GRIN3A Q8TCU5 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1083547 0.82 MAPK14 (0.61) MEN1KMT2ACYP2C9CYP2C19MAPK14
SCHEMBL14559811 0.76 CYP2C9 (0.61) MEN1KMT2ACYP2C9CYP2C19MAPK14
SCHEMBL5383885 0.76 GPR84 (0.51) MEN1KMT2ACYP2C9CYP2C19MAPK14
SCHEMBL8707313 0.75 TPSAB1 (0.61) MEN1KMT2ACYP2C9CYP2C19MAPK14
SCHEMBL8707900 0.75 MAPK14 (0.60) MEN1KMT2ACYP2C9CYP2C19MAPK14
SCHEMBL10720113 0.74 CYP2C9 (0.81) MEN1KMT2ACYP2C9CYP2C19MAPK14
SCHEMBL7234134 0.74 CYP2C9 (1.00) MEN1KMT2ACYP2C9CYP2C19MAPK14
SCHEMBL3463671 0.74 CYP2C9 (1.00) MEN1KMT2ACYP2C9CYP2C19MAPK14
SCHEMBL1063927 0.74 CYP2C9 (0.61) CYP2C9CYP2C19MAPK14HTR2BGRIN2D
SCHEMBL8708970 0.73 CYP2C9 (0.60) MEN1KMT2ACYP2C9CYP2C19MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101102787-A Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same ALIOS BIOPHARMA INC (US) 2008-01-09 CN disclosed